688315.SS
Price:
$13.95
Market Cap:
$5.81B
Novogene Co., Ltd. is a global provider of comprehensive genomic services and advanced solutions. Its offerings span a wide array of genomic applications, including human, animal, plant, and microbial genome sequencing, alongside gene regulation and single-cell sequencing technologies. The company also specializes in cancer genomic profiling, whole exome sequencing (including clinical-grade versions), and FFPE RNA sequencing. Furthermore, Novogene develops proprietary tools such as NovoFocus, a next-generation sequencing (NGS)-based companion diagnostic for PARP inhibitor treatments, and NovoNeoantigen, a bioinformatics pipeline that identifies cancer neoantigens by analyzing whole exome and...[Read more]
Industry
Biotechnology
IPO Date
2021-04-13
Stock Exchange
SHH
Ticker
688315.SS
According to Novogene Co., Ltd.’s latest financial reports and current stock price. The company's current ROE is 5.57%. This represents a change of 299.82% compared to the average of 1.39% of the last 4 quarters.
The mean historical ROE of Novogene Co., Ltd. over the last ten years is 8.11%. The current 5.57% ROE has changed -31.29% with respect to the historical average. Over the past ten years (40 quarters), 688315.SS's ROE was at its highest in in the December 2020 quarter at 7.95%. The ROE was at its lowest in in the March 2020 quarter at -6.11%.
Average
8.11%
Median
8.46%
Minimum
3.27%
Maximum
12.57%
Discovering the peaks and valleys of Novogene Co., Ltd. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 283.95%
Maximum Annual ROE = 12.57%
Minimum Annual Increase = -91.93%
Minimum Annual ROE = 3.27%
| Year | ROE | Change |
|---|---|---|
| 2025 | 6.26% | -20.78% |
| 2024 | 7.90% | 9.08% |
| 2023 | 7.25% | -19.67% |
| 2022 | 9.02% | -28.23% |
| 2021 | 12.57% | 283.95% |
| 2020 | 3.27% | -68.99% |
| 2019 | 10.56% | 5.21% |
| 2018 | 10.03% | 7.57% |
| 2017 | 9.33% | 88.91% |
| 2016 | 4.94% | -91.93% |
The current ROE of Novogene Co., Ltd. (688315.SS) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
7.14%
5-year avg
8.60%
10-year avg
8.11%
Novogene Co., Ltd.’s ROE is less than Hefei Lifeon Pharmaceutical Co., Ltd. (8.99%), less than Hangzhou Biotest Biotech Co.,Ltd. (0.77%), less than Jiangxi Fushine Pharmaceutical Co., Ltd. (5.76%), less than Xiangxue Pharmaceutical Co.,Ltd. (743.49%), less than Assure Tech (Hangzhou) Co., Ltd. (0.07%), greater than Beijing Kawin Technology Share-Holding Co., Ltd. (-0.03%), less than Pulike Biological Engineering, Inc. (5.63%), less than Qingdao NovelBeam Technology Co.,Ltd. (12.88%), greater than Jiangsu Aidea Pharmaceutical Co., Ltd. (-0.63%), greater than GuiZhou SanLi Pharmaceutical Co.,Ltd (0.03%),
| Company | ROE | Market cap |
|---|---|---|
| 8.99% | $4.04B | |
| 0.77% | $5.60B | |
| 5.76% | $9.85B | |
| 743.49% | $4.32B | |
| 0.07% | $3.72B | |
| -0.03% | $2.99B | |
| 5.63% | $3.62B | |
| 12.88% | $9.81B | |
| -0.63% | $6.50B | |
| 0.03% | $4.94B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Novogene Co., Ltd. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Novogene Co., Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Novogene Co., Ltd.'s ROE?
How is the ROE calculated for Novogene Co., Ltd. (688315.SS)?
What is the highest ROE for Novogene Co., Ltd. (688315.SS)?
What is the 3-year average ROE for Novogene Co., Ltd. (688315.SS)?
What is the 5-year average ROE for Novogene Co., Ltd. (688315.SS)?
How does the current ROE for Novogene Co., Ltd. (688315.SS) compare to its historical average?